[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Alzheimer Disease Genetic Testing Supply, Demand and Key Producers, 2023-2029

May 2023 | 110 pages | ID: G4DB168F4E5BEN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Alzheimer Disease Genetic Testing market size is expected to reach $ 358.7 million by 2029, rising at a market growth of 17.6% CAGR during the forecast period (2023-2029).

Alzheimer's disease is a neurodegenerative disorder that affects memory, cognitive functions, and behavior. While there is no cure for Alzheimer's disease, early detection and treatment can help slow the progression of the disease. Genetic testing can be a useful tool in identifying individuals who may be at higher risk of developing Alzheimer's disease.

This report studies the global Alzheimer Disease Genetic Testing demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Alzheimer Disease Genetic Testing, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Alzheimer Disease Genetic Testing that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Alzheimer Disease Genetic Testing total market, 2018-2029, (USD Million)

Global Alzheimer Disease Genetic Testing total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Alzheimer Disease Genetic Testing total market, key domestic companies and share, (USD Million)

Global Alzheimer Disease Genetic Testing revenue by player and market share 2018-2023, (USD Million)

Global Alzheimer Disease Genetic Testing total market by Type, CAGR, 2018-2029, (USD Million)

Global Alzheimer Disease Genetic Testing total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Alzheimer Disease Genetic Testing market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mega Genomics, Blueprint Genetics, Generi-Biotech, RxHomeTest, Kashi Labs, 23andMe, LabCorp, Empower DX and SolGent, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Alzheimer Disease Genetic Testing market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Alzheimer Disease Genetic Testing Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Alzheimer Disease Genetic Testing Market, Segmentation by Type
  • Early-Onset Alzheimer Disease
  • Late-Onset Alzheimer Disease
Global Alzheimer Disease Genetic Testing Market, Segmentation by Application
  • Online
  • Offline
Companies Profiled:
  • Mega Genomics
  • Blueprint Genetics
  • Generi-Biotech
  • RxHomeTest
  • Kashi Labs
  • 23andMe
  • LabCorp
  • Empower DX
  • SolGent
  • CapitalBio
  • Genex Diagnostics
  • Sansure
Key Questions Answered

1. How big is the global Alzheimer Disease Genetic Testing market?

2. What is the demand of the global Alzheimer Disease Genetic Testing market?

3. What is the year over year growth of the global Alzheimer Disease Genetic Testing market?

4. What is the total value of the global Alzheimer Disease Genetic Testing market?

5. Who are the major players in the global Alzheimer Disease Genetic Testing market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Alzheimer Disease Genetic Testing Introduction
1.2 World Alzheimer Disease Genetic Testing Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Alzheimer Disease Genetic Testing Total Market by Region (by Headquarter Location)
  1.3.1 World Alzheimer Disease Genetic Testing Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Alzheimer Disease Genetic Testing Market Size (2018-2029)
  1.3.3 China Alzheimer Disease Genetic Testing Market Size (2018-2029)
  1.3.4 Europe Alzheimer Disease Genetic Testing Market Size (2018-2029)
  1.3.5 Japan Alzheimer Disease Genetic Testing Market Size (2018-2029)
  1.3.6 South Korea Alzheimer Disease Genetic Testing Market Size (2018-2029)
  1.3.7 ASEAN Alzheimer Disease Genetic Testing Market Size (2018-2029)
  1.3.8 India Alzheimer Disease Genetic Testing Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Alzheimer Disease Genetic Testing Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Alzheimer Disease Genetic Testing Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Alzheimer Disease Genetic Testing Consumption Value (2018-2029)
2.2 World Alzheimer Disease Genetic Testing Consumption Value by Region
  2.2.1 World Alzheimer Disease Genetic Testing Consumption Value by Region (2018-2023)
  2.2.2 World Alzheimer Disease Genetic Testing Consumption Value Forecast by Region (2024-2029)
2.3 United States Alzheimer Disease Genetic Testing Consumption Value (2018-2029)
2.4 China Alzheimer Disease Genetic Testing Consumption Value (2018-2029)
2.5 Europe Alzheimer Disease Genetic Testing Consumption Value (2018-2029)
2.6 Japan Alzheimer Disease Genetic Testing Consumption Value (2018-2029)
2.7 South Korea Alzheimer Disease Genetic Testing Consumption Value (2018-2029)
2.8 ASEAN Alzheimer Disease Genetic Testing Consumption Value (2018-2029)
2.9 India Alzheimer Disease Genetic Testing Consumption Value (2018-2029)

3 WORLD ALZHEIMER DISEASE GENETIC TESTING COMPANIES COMPETITIVE ANALYSIS

3.1 World Alzheimer Disease Genetic Testing Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Alzheimer Disease Genetic Testing Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Alzheimer Disease Genetic Testing in 2022
  3.2.3 Global Concentration Ratios (CR8) for Alzheimer Disease Genetic Testing in 2022
3.3 Alzheimer Disease Genetic Testing Company Evaluation Quadrant
3.4 Alzheimer Disease Genetic Testing Market: Overall Company Footprint Analysis
  3.4.1 Alzheimer Disease Genetic Testing Market: Region Footprint
  3.4.2 Alzheimer Disease Genetic Testing Market: Company Product Type Footprint
  3.4.3 Alzheimer Disease Genetic Testing Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Alzheimer Disease Genetic Testing Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Alzheimer Disease Genetic Testing Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Alzheimer Disease Genetic Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Alzheimer Disease Genetic Testing Consumption Value Comparison
  4.2.1 United States VS China: Alzheimer Disease Genetic Testing Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Alzheimer Disease Genetic Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Alzheimer Disease Genetic Testing Companies and Market Share, 2018-2023
  4.3.1 United States Based Alzheimer Disease Genetic Testing Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Alzheimer Disease Genetic Testing Revenue, (2018-2023)
4.4 China Based Companies Alzheimer Disease Genetic Testing Revenue and Market Share, 2018-2023
  4.4.1 China Based Alzheimer Disease Genetic Testing Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Alzheimer Disease Genetic Testing Revenue, (2018-2023)
4.5 Rest of World Based Alzheimer Disease Genetic Testing Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Alzheimer Disease Genetic Testing Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Alzheimer Disease Genetic Testing Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Alzheimer Disease Genetic Testing Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Early-Onset Alzheimer Disease
  5.2.2 Late-Onset Alzheimer Disease
5.3 Market Segment by Type
  5.3.1 World Alzheimer Disease Genetic Testing Market Size by Type (2018-2023)
  5.3.2 World Alzheimer Disease Genetic Testing Market Size by Type (2024-2029)
  5.3.3 World Alzheimer Disease Genetic Testing Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Alzheimer Disease Genetic Testing Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Online
  6.2.2 Offline
6.3 Market Segment by Application
  6.3.1 World Alzheimer Disease Genetic Testing Market Size by Application (2018-2023)
  6.3.2 World Alzheimer Disease Genetic Testing Market Size by Application (2024-2029)
  6.3.3 World Alzheimer Disease Genetic Testing Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Mega Genomics
  7.1.1 Mega Genomics Details
  7.1.2 Mega Genomics Major Business
  7.1.3 Mega Genomics Alzheimer Disease Genetic Testing Product and Services
  7.1.4 Mega Genomics Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Mega Genomics Recent Developments/Updates
  7.1.6 Mega Genomics Competitive Strengths & Weaknesses
7.2 Blueprint Genetics
  7.2.1 Blueprint Genetics Details
  7.2.2 Blueprint Genetics Major Business
  7.2.3 Blueprint Genetics Alzheimer Disease Genetic Testing Product and Services
  7.2.4 Blueprint Genetics Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Blueprint Genetics Recent Developments/Updates
  7.2.6 Blueprint Genetics Competitive Strengths & Weaknesses
7.3 Generi-Biotech
  7.3.1 Generi-Biotech Details
  7.3.2 Generi-Biotech Major Business
  7.3.3 Generi-Biotech Alzheimer Disease Genetic Testing Product and Services
  7.3.4 Generi-Biotech Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Generi-Biotech Recent Developments/Updates
  7.3.6 Generi-Biotech Competitive Strengths & Weaknesses
7.4 RxHomeTest
  7.4.1 RxHomeTest Details
  7.4.2 RxHomeTest Major Business
  7.4.3 RxHomeTest Alzheimer Disease Genetic Testing Product and Services
  7.4.4 RxHomeTest Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 RxHomeTest Recent Developments/Updates
  7.4.6 RxHomeTest Competitive Strengths & Weaknesses
7.5 Kashi Labs
  7.5.1 Kashi Labs Details
  7.5.2 Kashi Labs Major Business
  7.5.3 Kashi Labs Alzheimer Disease Genetic Testing Product and Services
  7.5.4 Kashi Labs Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Kashi Labs Recent Developments/Updates
  7.5.6 Kashi Labs Competitive Strengths & Weaknesses
7.6 23andMe
  7.6.1 23andMe Details
  7.6.2 23andMe Major Business
  7.6.3 23andMe Alzheimer Disease Genetic Testing Product and Services
  7.6.4 23andMe Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 23andMe Recent Developments/Updates
  7.6.6 23andMe Competitive Strengths & Weaknesses
7.7 LabCorp
  7.7.1 LabCorp Details
  7.7.2 LabCorp Major Business
  7.7.3 LabCorp Alzheimer Disease Genetic Testing Product and Services
  7.7.4 LabCorp Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 LabCorp Recent Developments/Updates
  7.7.6 LabCorp Competitive Strengths & Weaknesses
7.8 Empower DX
  7.8.1 Empower DX Details
  7.8.2 Empower DX Major Business
  7.8.3 Empower DX Alzheimer Disease Genetic Testing Product and Services
  7.8.4 Empower DX Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Empower DX Recent Developments/Updates
  7.8.6 Empower DX Competitive Strengths & Weaknesses
7.9 SolGent
  7.9.1 SolGent Details
  7.9.2 SolGent Major Business
  7.9.3 SolGent Alzheimer Disease Genetic Testing Product and Services
  7.9.4 SolGent Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 SolGent Recent Developments/Updates
  7.9.6 SolGent Competitive Strengths & Weaknesses
7.10 CapitalBio
  7.10.1 CapitalBio Details
  7.10.2 CapitalBio Major Business
  7.10.3 CapitalBio Alzheimer Disease Genetic Testing Product and Services
  7.10.4 CapitalBio Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 CapitalBio Recent Developments/Updates
  7.10.6 CapitalBio Competitive Strengths & Weaknesses
7.11 Genex Diagnostics
  7.11.1 Genex Diagnostics Details
  7.11.2 Genex Diagnostics Major Business
  7.11.3 Genex Diagnostics Alzheimer Disease Genetic Testing Product and Services
  7.11.4 Genex Diagnostics Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Genex Diagnostics Recent Developments/Updates
  7.11.6 Genex Diagnostics Competitive Strengths & Weaknesses
7.12 Sansure
  7.12.1 Sansure Details
  7.12.2 Sansure Major Business
  7.12.3 Sansure Alzheimer Disease Genetic Testing Product and Services
  7.12.4 Sansure Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 Sansure Recent Developments/Updates
  7.12.6 Sansure Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Alzheimer Disease Genetic Testing Industry Chain
8.2 Alzheimer Disease Genetic Testing Upstream Analysis
8.3 Alzheimer Disease Genetic Testing Midstream Analysis
8.4 Alzheimer Disease Genetic Testing Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Alzheimer Disease Genetic Testing Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Alzheimer Disease Genetic Testing Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Alzheimer Disease Genetic Testing Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Alzheimer Disease Genetic Testing Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Alzheimer Disease Genetic Testing Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Alzheimer Disease Genetic Testing Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Alzheimer Disease Genetic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Alzheimer Disease Genetic Testing Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Alzheimer Disease Genetic Testing Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Alzheimer Disease Genetic Testing Players in 2022
Table 12. World Alzheimer Disease Genetic Testing Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Alzheimer Disease Genetic Testing Company Evaluation Quadrant
Table 14. Head Office of Key Alzheimer Disease Genetic Testing Player
Table 15. Alzheimer Disease Genetic Testing Market: Company Product Type Footprint
Table 16. Alzheimer Disease Genetic Testing Market: Company Product Application Footprint
Table 17. Alzheimer Disease Genetic Testing Mergers & Acquisitions Activity
Table 18. United States VS China Alzheimer Disease Genetic Testing Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Alzheimer Disease Genetic Testing Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Alzheimer Disease Genetic Testing Companies, Headquarters (States, Country)
Table 21. United States Based Companies Alzheimer Disease Genetic Testing Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Alzheimer Disease Genetic Testing Revenue Market Share (2018-2023)
Table 23. China Based Alzheimer Disease Genetic Testing Companies, Headquarters (Province, Country)
Table 24. China Based Companies Alzheimer Disease Genetic Testing Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Alzheimer Disease Genetic Testing Revenue Market Share (2018-2023)
Table 26. Rest of World Based Alzheimer Disease Genetic Testing Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Alzheimer Disease Genetic Testing Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Alzheimer Disease Genetic Testing Revenue Market Share (2018-2023)
Table 29. World Alzheimer Disease Genetic Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Alzheimer Disease Genetic Testing Market Size by Type (2018-2023) & (USD Million)
Table 31. World Alzheimer Disease Genetic Testing Market Size by Type (2024-2029) & (USD Million)
Table 32. World Alzheimer Disease Genetic Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Alzheimer Disease Genetic Testing Market Size by Application (2018-2023) & (USD Million)
Table 34. World Alzheimer Disease Genetic Testing Market Size by Application (2024-2029) & (USD Million)
Table 35. Mega Genomics Basic Information, Area Served and Competitors
Table 36. Mega Genomics Major Business
Table 37. Mega Genomics Alzheimer Disease Genetic Testing Product and Services
Table 38. Mega Genomics Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Mega Genomics Recent Developments/Updates
Table 40. Mega Genomics Competitive Strengths & Weaknesses
Table 41. Blueprint Genetics Basic Information, Area Served and Competitors
Table 42. Blueprint Genetics Major Business
Table 43. Blueprint Genetics Alzheimer Disease Genetic Testing Product and Services
Table 44. Blueprint Genetics Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Blueprint Genetics Recent Developments/Updates
Table 46. Blueprint Genetics Competitive Strengths & Weaknesses
Table 47. Generi-Biotech Basic Information, Area Served and Competitors
Table 48. Generi-Biotech Major Business
Table 49. Generi-Biotech Alzheimer Disease Genetic Testing Product and Services
Table 50. Generi-Biotech Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Generi-Biotech Recent Developments/Updates
Table 52. Generi-Biotech Competitive Strengths & Weaknesses
Table 53. RxHomeTest Basic Information, Area Served and Competitors
Table 54. RxHomeTest Major Business
Table 55. RxHomeTest Alzheimer Disease Genetic Testing Product and Services
Table 56. RxHomeTest Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. RxHomeTest Recent Developments/Updates
Table 58. RxHomeTest Competitive Strengths & Weaknesses
Table 59. Kashi Labs Basic Information, Area Served and Competitors
Table 60. Kashi Labs Major Business
Table 61. Kashi Labs Alzheimer Disease Genetic Testing Product and Services
Table 62. Kashi Labs Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Kashi Labs Recent Developments/Updates
Table 64. Kashi Labs Competitive Strengths & Weaknesses
Table 65. 23andMe Basic Information, Area Served and Competitors
Table 66. 23andMe Major Business
Table 67. 23andMe Alzheimer Disease Genetic Testing Product and Services
Table 68. 23andMe Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. 23andMe Recent Developments/Updates
Table 70. 23andMe Competitive Strengths & Weaknesses
Table 71. LabCorp Basic Information, Area Served and Competitors
Table 72. LabCorp Major Business
Table 73. LabCorp Alzheimer Disease Genetic Testing Product and Services
Table 74. LabCorp Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. LabCorp Recent Developments/Updates
Table 76. LabCorp Competitive Strengths & Weaknesses
Table 77. Empower DX Basic Information, Area Served and Competitors
Table 78. Empower DX Major Business
Table 79. Empower DX Alzheimer Disease Genetic Testing Product and Services
Table 80. Empower DX Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Empower DX Recent Developments/Updates
Table 82. Empower DX Competitive Strengths & Weaknesses
Table 83. SolGent Basic Information, Area Served and Competitors
Table 84. SolGent Major Business
Table 85. SolGent Alzheimer Disease Genetic Testing Product and Services
Table 86. SolGent Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. SolGent Recent Developments/Updates
Table 88. SolGent Competitive Strengths & Weaknesses
Table 89. CapitalBio Basic Information, Area Served and Competitors
Table 90. CapitalBio Major Business
Table 91. CapitalBio Alzheimer Disease Genetic Testing Product and Services
Table 92. CapitalBio Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. CapitalBio Recent Developments/Updates
Table 94. CapitalBio Competitive Strengths & Weaknesses
Table 95. Genex Diagnostics Basic Information, Area Served and Competitors
Table 96. Genex Diagnostics Major Business
Table 97. Genex Diagnostics Alzheimer Disease Genetic Testing Product and Services
Table 98. Genex Diagnostics Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Genex Diagnostics Recent Developments/Updates
Table 100. Sansure Basic Information, Area Served and Competitors
Table 101. Sansure Major Business
Table 102. Sansure Alzheimer Disease Genetic Testing Product and Services
Table 103. Sansure Alzheimer Disease Genetic Testing Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Alzheimer Disease Genetic Testing Upstream (Raw Materials)
Table 105. Alzheimer Disease Genetic Testing Typical Customers

LIST OF FIGURES

Figure 1. Alzheimer Disease Genetic Testing Picture
Figure 2. World Alzheimer Disease Genetic Testing Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Alzheimer Disease Genetic Testing Total Market Size (2018-2029) & (USD Million)
Figure 4. World Alzheimer Disease Genetic Testing Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Alzheimer Disease Genetic Testing Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Alzheimer Disease Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Alzheimer Disease Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Alzheimer Disease Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Alzheimer Disease Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Alzheimer Disease Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Alzheimer Disease Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Alzheimer Disease Genetic Testing Revenue (2018-2029) & (USD Million)
Figure 13. Alzheimer Disease Genetic Testing Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Alzheimer Disease Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 16. World Alzheimer Disease Genetic Testing Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Alzheimer Disease Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. China Alzheimer Disease Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Alzheimer Disease Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Alzheimer Disease Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Alzheimer Disease Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Alzheimer Disease Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 23. India Alzheimer Disease Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Alzheimer Disease Genetic Testing by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Alzheimer Disease Genetic Testing Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Alzheimer Disease Genetic Testing Markets in 2022
Figure 27. United States VS China: Alzheimer Disease Genetic Testing Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Alzheimer Disease Genetic Testing Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Alzheimer Disease Genetic Testing Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Alzheimer Disease Genetic Testing Market Size Market Share by Type in 2022
Figure 31. Early-Onset Alzheimer Disease
Figure 32. Late-Onset Alzheimer Disease
Figure 33. World Alzheimer Disease Genetic Testing Market Size Market Share by Type (2018-2029)
Figure 34. World Alzheimer Disease Genetic Testing Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Alzheimer Disease Genetic Testing Market Size Market Share by Application in 2022
Figure 36. Online
Figure 37. Offline
Figure 38. Alzheimer Disease Genetic Testing Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source


More Publications